Vantive US Healthcare services and products

Vantive is a leading global healthcare company focused on vital organ therapies and acute care. Originally conceived as a strategic transformation of Baxter International's Renal Care and Acute Therapies businesses, Vantive was established to operate as a standalone entity dedicated to improving outcomes for patients with kidney disease and other critical conditions. The brand's heritage is deeply rooted in the history of Baxter, a pioneer in dialysis technology and intravenous therapies.

As of 2025 and 2026, Vantive has transitioned to independent ownership following its acquisition by the global investment firm Carlyle. The company maintains a significant manufacturing and research presence in the United States, while utilizing a global supply chain to provide life-sustaining technologies—including peritoneal dialysis, hemodialysis, and continuous renal replacement therapies—to hospitals and clinics worldwide. The brand represents a major shift in the medical technology landscape, focusing on innovation in chronic and acute organ support.